UOC
VRDN icon

UBS O'Connor’s Viridian Therapeutics VRDN Stock Holding History

UBS O'Connor’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-131,294
Closed -$1.84M – 502
2025
Q2 		$1.84M Buy
131,294
+24,206
+23% +$329K 0.05% 169
2025
Q1 		$1.44M Buy
107,088
+62,488
+140% +$1.06M 0.03% 151
2024
Q4 		$855K Buy
+44,600
New +$970K 0.02% 243
2024
Q3 		– Sell
-10,057
Closed -$131K – 672
2024
Q2 		$131K Sell
10,057
-6,400
-39% -$88.6K ﹤0.01% 423
2024
Q1 		$288K Sell
16,457
-13,543
-45% -$263K 0.01% 371
2023
Q4 		$653K Sell
30,000
-54,836
-65% -$866K 0.02% 322
2023
Q3 		$1.3M Buy
84,836
+10,000
+13% +$191K 0.02% 299
2023
Q2 		$1.78M Buy
74,836
+11,293
+18% +$290K 0.04% 320
2023
Q1 		$1.62M Buy
+63,543
New +$2.04M 0.04% 358
2022
Q4 		– Sell
-81,870
Closed -$1.68M – 358
2022
Q3 		$1.68M Buy
81,870
+47,481
+138% +$854K 0.02% 671
2022
Q2 		$398K Buy
+34,389
New +$462K ﹤0.01% 826

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return